Fintel PLC Boosts Software & Data Division with Strategic Acquisition of Pearson Ham's Insurance Pricing Business

Fintel buys Pearson Ham’s insurance pricing data: what’s changed?

Fintel has snapped up Pearson Ham Group’s Market Pricing Business, a provider of proprietary insurance pricing data, for £11.0 million in cash. The deal is being folded into Defaqto, Fintel’s technology and ratings arm, and is aimed squarely at beefing up the Software & Data division.

The prize here is pricing intelligence across key personal lines – motor, home, travel and pet. Combined with Defaqto’s product data, this gives Fintel a broader dataset to power ratings, benchmarking and market intelligence for insurers and price comparison players. Management say the acquisition will be earnings accretive in the year to 31 December 2026.

In plain English: more proprietary data, more ways to monetise it, and a clearer runway to AI-driven tools in insurance.

Deal terms and the FY26 numbers that matter

Total consideration	£11.0 million (cash)
Initial payment	£7.5 million (on completion)
Deferred payments	£2.0 million in April 2026; £1.5 million in July 2026
Expected FY26 revenue	£2.6 million
Expected FY26 EBITDA	£0.9 million
Earnings impact	Net earnings accretive in FY26 (after interest and tax)
Funding	Existing financial resources, drawing on the £120 million RCF announced July 2025

“Earnings accretive” means the deal should lift Fintel’s earnings per share in FY26 once financing costs and tax are counted. EBITDA is earnings before interest, tax, depreciation and amortisation – a common proxy for operating cash profit. The acquisition has been funded without issuing equity, which avoids dilution for shareholders.

Why this data asset fits Defaqto’s strategy

Defaqto already sits on a rich bed of product data and well-known Star Ratings. Adding live market pricing data strengthens the proposition for insurers and distributors who want to understand both product features and price dynamics in one place.

• Comprehensive datasets: Fintel says Defaqto will now offer the most extensive combined product and pricing datasets in UK personal lines insurance, spanning motor, home, travel and pet.
• Technology leverage: Matrix360 – Defaqto’s market intelligence platform – has already been adopted by 22 major insurers. Plugging in pricing data should accelerate feature development and deepen usage.
• AI-ready foundations: Proprietary data underpins new tools, including upcoming “value for money” ratings and advanced benchmarking. In an AI-driven economy, unique data is the moat.

The strategic logic is straightforward: better data – both breadth and depth – improves ratings, benchmarking and decision tools. Insurers want to optimise pricing, product positioning and distribution; price comparison sites want sharper, more granular insight. Defaqto is positioning itself as the data and software layer that powers those decisions.

What it could mean for growth, margins and returns

The acquired business is described as profitable, growing and cash generative, with a “rich historic data set”. For FY26, the target is £2.6 million of revenue and £0.9 million of EBITDA, implying an EBITDA margin in the mid-30s on those disclosed expectations.

On the headline price of £11.0 million, that equates to roughly 4.2x FY26 revenue and about 12.2x FY26 EBITDA, based on the RNS figures. Whether that proves attractive will hinge on three things:

• Cross-sell and upsell: Can Defaqto sell more Matrix360 modules, ratings enhancements and analytics to existing insurer clients with the pricing data now in the stack?
• Product velocity: How quickly do “value for money” ratings and AI-led benchmarking tools reach commercial scale?
• Churn and resilience: Pricing data is sticky if it’s embedded in workflows. The stickier it is, the better the lifetime economics.

The deal is funded from Fintel’s revolving credit facility (RCF) on competitive terms, which keeps equity intact. Management explicitly flag that, after interest and tax, the acquisition will lift earnings in FY26. That suggests FY25 is likely neutral or modestly dilutive on EPS as integration and finance costs come through, but the RNS doesn’t quantify the near-term impact.

Operational angles: integration, incentives and clients

The business slots into Defaqto. Integration matters in data acquisitions – schemas, quality controls and timeliness of updates are the lifeblood of pricing intelligence. The RNS notes a separate Growth Share Plan will be implemented to retain and incentivise key managers in the acquired business. Structure and potential dilution, if any, are not disclosed.

Client-side, the logic is strong. Defaqto already counts 22 major insurers using Matrix360. Adding market pricing data should raise the platform’s utility, improve benchmarking, and potentially support additional modules. The key is execution: onboarding the pricing feeds cleanly and surfacing insights simply enough for underwriting, pricing and distribution teams to act on them.

The AI angle: data as the differentiator

Fintel is explicit that “the winners in the AI economy” will have unique, proprietary data. That rings true. Generative and agentic AI tools are only as good as the data they’re trained and tuned on. Combining product specifications with observed market pricing can power smarter “value for money” ratings and more credible benchmarking – the kind of decision support insurers, providers and price comparison sites will pay for.

The flywheel is clear: more data drives better models, better models drive better products, which attract more clients and data. If Defaqto executes, this acquisition strengthens that loop.

Risks and watch-outs for shareholders

• Integration risk: Merging pricing datasets with existing product data is non-trivial. Any disruption to data timeliness or quality could dent client trust.
• Commercialisation pace: The RNS doesn’t set targets for Matrix360 growth or “value for money” roll-out. If monetisation lags, the return profile stretches.
• Competitive response: Price comparison sites and analytics vendors won’t stand still. Defaqto’s ability to keep features fresh will be tested.
• Disclosure gaps: No purchase price allocation, synergies, or near-term EPS impact were disclosed beyond FY26 accretion. The Growth Share Plan details are also not disclosed.

Bottom line: a tidy, strategically coherent bolt-on

On the face of it, this is a neat bolt-on that deepens Defaqto’s data moat, is sensibly funded, and lines up with Fintel’s push to be the UK financial services sector’s strategic technology and data partner. It adds a growing, cash generative pricing dataset to an already strong product data franchise.

Positives: clear strategic fit, proprietary data, AI enablement, no equity raise, FY26 earnings accretion. Negatives: limited near-term EPS clarity, no synergy guidance, and the usual integration risks. If Defaqto executes on product innovation and cross-sell, this acquisition should help compound the Software & Data division’s growth through 2026.

For now, it’s a sensible swing at a high-value niche. The next proof points to watch: additional Matrix360 adoption beyond the current 22 major insurers, visible new AI-led features, and confirmation that the acquired business hits that £0.9 million FY26 EBITDA target.